Showing results (91-100 of 638) with videos related to
Sort By:
Pageof 64
Circulation|May 1, 1993
Does obesity influence early target organ damage in hypertensive patients?R E Schmieder, F H MesserliSchweizerische Medizinische Wochenschrift|January 30, 1993
[Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor]R E Schmieder, F H MesserliJournal of Cardiovascular Pharmacology|January 1, 1990
Reversal of left ventricular hypertrophy: a desirable therapeutic goal?R E Schmieder, F H MesserliDrugs|January 1, 1985
Cardiovascular pathophysiology of essential hypertension: a clue to therapyF H Messerli, H O VenturaClinics in Geriatric Medicine|May 1, 1990
Antihypertensive therapy in the elderlyF H Messerli, C J LosemJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 21, 2001
The choice of first-line therapy: rationale for low-dose combinations of an angiotensin converting enzyme inhibitor and a diureticL H Opie, F H MesserliJournal of Human Hypertension|November 30, 2000
Hypertension and the heartR E Schmieder, F H MesserliThe American Journal of Medicine|April 27, 1992
Is the decrease in arterial pressure the sole factor for reduction of left ventricular hypertrophy?R E Schmieder, F H MesserliThe American Journal of Cardiology|November 25, 2000
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertensionF H Messerli, S Oparil, Z FengPageof 64